Stock Market News2 days GSK’s Jemperli Gets EU Nod for Expanded Use in Endometrial Cancer Zacks
The European Commission approves GSK’s Jemperli plus chemotherapy to treat all adult patients with primary, advanced or recurrent endometrial cancer.
XThe European Commission approves GSK’s Jemperli plus chemotherapy to treat all adult patients with primary, advanced or recurrent endometrial cancer.
X